Capital Fund Management (CFM)
MRK icon

Capital Fund Management (CFM)’s Merck MRK Stock Holding History

Capital Fund Management (CFM)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,747
Closed -$5.51M – 2380
2025
Q4 		$5.03M Sell
47,747
-485,603
-91% -$45.6M 0.01% 1192
2025
Q3 		$44.8M Sell
533,350
-420,203
-44% -$34.6M 0.12% 220
2025
Q2 		$75.5M Sell
953,553
-443,352
-32% -$35.2M 0.21% 108
2025
Q1 		$125M Buy
1,396,905
+612,690
+78% +$57.2M 0.36% 39
2024
Q4 		$78M Sell
784,215
-128,717
-14% -$13.3M 0.2% 138
2024
Q3 		$104M Buy
912,932
+788,335
+633% +$93.7M 0.28% 78
2024
Q2 		$15.4M Buy
124,597
+26,288
+27% +$3.39M 0.05% 507
2024
Q1 		$13M Buy
+98,309
New +$12.1M 0.04% 614
2023
Q4 		– Sell
-123,270
Closed -$12.8M – 2234
2023
Q3 		$12.7M Buy
+123,270
New +$13.3M 0.04% 511
2023
Q1 		– Sell
-295,467
Closed -$31.9M – 1680
2022
Q4 		$32.8M Buy
295,467
+237,111
+406% +$24.2M 0.22% 111
2022
Q3 		$5.03M Sell
58,356
-318,098
-84% -$28.4M 0.04% 539
2022
Q2 		$34.3M Buy
376,454
+293,566
+354% +$26M 0.31% 59
2022
Q1 		$6.8M Sell
82,888
-6,731
-8% -$531K 0.06% 469
2021
Q4 		$6.87M Buy
89,619
+62,835
+235% +$5M 0.05% 519
2021
Q3 		$2.01M Sell
26,784
-44,602
-62% -$3.39M 0.01% 939
2021
Q2 		$5.55M Buy
+71,386
New +$5.31M 0.04% 526
2021
Q1 		– Sell
-17,686
Closed -$1.38M – 1495
2020
Q4 		$1.38M Sell
17,686
-89,212
-83% -$6.82M 0.01% 896
2020
Q3 		$8.46M Sell
106,898
-16,857
-14% -$1.32M 0.1% 234
2020
Q2 		$9.13M Sell
123,755
-751,767
-86% -$56.6M 0.14% 206
2020
Q1 		$64.3M Buy
875,522
+478,367
+120% +$37.6M 0.99% 5
2019
Q4 		$34.5M Buy
397,155
+152,170
+62% +$12.5M 0.27% 91
2019
Q3 		$19.7M Sell
244,985
-659,649
-73% -$52.9M 0.18% 158
2019
Q2 		$72.4M Sell
904,634
-38,279
-4% -$2.93M 0.66% 10
2019
Q1 		$74.8M Buy
942,913
+837,562
+795% +$62.6M 0.67% 13
2018
Q4 		$7.68M Buy
+105,351
New +$7.44M 0.07% 382
2018
Q2 		– Sell
-120,642
Closed -$6.81M – 2181
2018
Q1 		$6.27M Sell
120,642
-1,009,540
-89% -$54.5M 0.04% 602
2017
Q4 		$60.7M Sell
1,130,182
-404,214
-26% -$22.4M 0.33% 61
2017
Q3 		$93.7M Sell
1,534,396
-380,738
-20% -$23.1M 0.67% 19
2017
Q2 		$117M Sell
1,915,134
-145,672
-7% -$8.87M 0.94% 6
2017
Q1 		$125M Buy
2,060,806
+1,924,515
+1,412% +$117M 1.04% 3
2016
Q4 		$7.66M Buy
136,291
+129,368
+1,869% +$7.57M 0.07% 365
2016
Q3 		$412K Buy
+6,923
New +$405K ﹤0.01% 1272
2016
Q2 		– Sell
-10,891
Closed -$580K – 1682
2016
Q1 		$550K Buy
+10,891
New +$533K 0.01% 1103
2015
Q1 		– Sell
-495,874
Closed -$28.1M – 1629
2014
Q4 		$26.9M Buy
495,874
+483,014
+3,756% +$26.9M 0.32% 70
2014
Q3 		$727K Buy
+12,860
New +$722K 0.01% 1029
2013
Q4 		– Sell
-116,056
Closed -$5.31M – 1772
2013
Q3 		$5.27M Buy
+116,056
New +$5.3M 0.07% 345

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Fund Management (CFM)'s MRK Position: Q1 2026 in Review

Capital Fund Management (CFM) sold out of Merck (MRK) in Q1 2026, closing a stake of 47,747 shares — an estimated $5.51M sold.

Capital Fund Management (CFM) first reported a position in MRK in Q3 2013 and held it in 36 quarters. The position peaked at $125M in Q1 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capital Fund Management (CFM) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 47,747 Merck shares in Q1 2026, an estimated $5.51M.
  • Capital Fund Management (CFM) first reported a position in Merck in Q3 2013 and held it in 36 quarters.
  • Capital Fund Management (CFM)'s Merck position peaked at $125M in Q1 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.